Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Starling Oncology, Inc.TOI · Entity 5327 | Director | December 26, 2023 | December 28, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Starling Oncology, Inc.
Report date December 26, 2023 · Filed December 28, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 109,104 |
Reported balance
After 2023-12-26 transaction · row 1
1 source rowRow 1 · 2023-12-26 · Grant · Acquired 50,000 · Balance 109,104 F1: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CASTLIGHT HEALTH, INC.
Report date January 12, 2022 · Filed February 18, 2022
Section 16 reporting ended · disclosed 2022-02-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 1
1 source rowRow 1 · 2022-02-17 · Disposition to issuer · Disposed 1,625,989 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger (the "Surviving Corporation"), as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 397,500 |
Reported balance
After 2022-01-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-01-12 · Grant · Acquired 397,500 · Balance 397,500 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F3: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-02-17 · Disposition to issuer · Disposed 12,500 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F4: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-02-17 · Disposition to issuer · Disposed 25,000 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F6: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-02-17 · Disposition to issuer · Disposed 115,313 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F7: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-02-17 · Disposition to issuer · Disposed 301,725 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F8: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-02-17 · Disposition to issuer · Disposed 558,000 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F9: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-02-17 · Disposition to issuer · Disposed 430,625 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F10: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Restricted Stock Units (RSU)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-02-17 · Disposition to issuer · Disposed 397,500 · Balance 0 F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F3: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.09 · Expires 2022-11-07 | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-02-17 · Disposition to issuer · Disposed 9,000 · Balance 0 F14: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. F11: The stock option is fully vested and immediately exercisable. F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.12 · Expires 2023-02-11 | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-02-17 · Disposition to issuer · Disposed 7,500 · Balance 0 F14: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. F11: The stock option is fully vested and immediately exercisable. F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.35 · Expires 2023-10-24 | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-02-17 · Disposition to issuer · Disposed 20,000 · Balance 0 F15: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F11: The stock option is fully vested and immediately exercisable. F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date. F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.99 · Expires 2026-02-23 | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2022-02-17 · Disposition to issuer · Disposed 155,000 · Balance 0 F15: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F11: The stock option is fully vested and immediately exercisable. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2030-03-02 | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2022-02-17 · Disposition to issuer · Disposed 331,000 · Balance 0 F17: Pursuant to the Merger Agreement, to the extent vested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. To the extent unvested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash replacement amount equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option cash equivalent award valued based on the excess of the Merger Consideration over the option exercise price (the "Option Consideration"). [continued in fn 18]. F18: [cont. from fn. 17] The payment of the Option Consideration will be subject to vesting in accordance with the vesting schedule applicable to the unvested portion of the option immediately prior to the Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date. F16: The option vested as to 1/5th of the total number of shares on March 3, 2021, and thereafter vests as to 1/36th monthly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger (the "Surviving Corporation"), as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time.
F2: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
F3: 1/3 of the RSUs vested on February 16, 2022 and the remainder will vest quarterly over two years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F4: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F5: Pursuant to the Merger Agreement, any RSUs that were unvested at the Effective Time were cancelled and converted at or immediately prior to the Effective Time into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration multiplied by (b) the total number of unvested shares subject to the RSUs (the "RSU Consideration"). The payment of the RSU Consideration will be subject to vesting in accordance with the vesting schedule applicable to such unvested RSUs immediately prior to Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date.
F6: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F7: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F8: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F9: 1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F10: 1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F11: The stock option is fully vested and immediately exercisable.
F12: Each share of Class A Common Stock is convertible at any time at the option of the holder into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect immediately prior to the Effective Time. The shares of Class A Common Stock have no expiration date.
F13: Each share of Class A Common Stock converted into one (1) share of Class B Common Stock at the Effective Time.
F14: Pursuant to the Merger Agreement, the option was cancelled and converted at or immediately prior to the Effective Time into a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option.
F15: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time.
F16: The option vested as to 1/5th of the total number of shares on March 3, 2021, and thereafter vests as to 1/36th monthly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
F17: Pursuant to the Merger Agreement, to the extent vested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash payment equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option. To the extent unvested, the option was cancelled and converted at or immediately prior to the Effective Time into the right to receive a cash replacement amount equal to the product of (a) the aggregate number of underlying shares multiplied by (b) the excess of the Merger Consideration over the applicable per share exercise price of the option cash equivalent award valued based on the excess of the Merger Consideration over the option exercise price (the "Option Consideration"). [continued in fn 18].
F18: [cont. from fn. 17] The payment of the Option Consideration will be subject to vesting in accordance with the vesting schedule applicable to the unvested portion of the option immediately prior to the Effective Time, subject to the Reporting Person remaining employed by or otherwise in service to the Surviving Corporation on each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2020 Filed Aug 12, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantRestricted Stock Units (RSU) · Derivative | 344,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-046496 · doc4.xml · derivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689,656 Underlying: Class B Common Stock · 344,828 shares Expires 2021-08-16 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: The first installment of shares underlying the RSUs was earned on November 16, 2019 and reported on a Form 4 filed with the Securities and Exchange Commission on November 19, 2019. The second and final installment of shares underlying the RSUs was earned on August 11, 2020 and are being reported on this Form 4. All shares underlying the RSU vest on August 17, 2020, subject to the continued service of the Reporting Person on such date. Read SEC document |
| March 12, 2020 Filed Mar 12, 2020 17:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | PurchaseClass B Common Stock | 75,000 | $0.82 | $61,687.50 |
DisclosureSEC source: 0001209191-20-018585 · doc4.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,453 F1 · price: Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $0.7583 to $0.8500 per share. Full information regarding the number of shares purchased at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 16:56 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantStock Option (Right to Buy) · Derivative | 331,000 | $0.00 Strike: $1.01 | $0.00 |
DisclosureSEC source: 0001209191-20-016653 · doc4.xml · derivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,000 Underlying: Class B Common Stock · 331,000 shares Expires 2030-03-03 F3 · derivative.exercise_date: 1/5th of the shares underlying the option will vest on March 3, 2021, and the remainder will vest 1/36th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 16:56 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantRestricted Stock Units (RSU) · Derivative | 992,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016653 · doc4.xml · derivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 992,000 Underlying: Class B Common Stock · 992,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: 1/16th of the RSUs will vest on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F2 · derivative.expiration_date: 1/16th of the RSUs will vest on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 38,140 | $1.23 | $46,832.11 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · nonDerivative · entry 7 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,453 F1 · kind: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.21 to $1.26 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 43,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · derivative · entry 13 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 603,449 Underlying: Class B Common Stock · 43,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9 · derivative.exercise_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F9 · derivative.expiration_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 23,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · derivative · entry 12 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,750 Underlying: Class B Common Stock · 23,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F8 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · derivative · entry 11 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7 · derivative.exercise_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F7 · derivative.expiration_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · derivative · entry 10 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F6 · derivative.expiration_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · derivative · entry 9 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Class B Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: 1/4th of the RSUs vested on March 7, 2018, and the remainder will vest 1/20th quarterly in 12 equal installments and then 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F5 · derivative.expiration_date: 1/4th of the RSUs vested on March 7, 2018, and the remainder will vest 1/20th quarterly in 12 equal installments and then 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 313 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · derivative · entry 8 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 313 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 1/4th of the RSUs vested on February 24, 2017, and the remainder will vest 1/20th in 12 equal installments, and then 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F4 · derivative.expiration_date: 1/4th of the RSUs vested on February 24, 2017, and the remainder will vest 1/20th in 12 equal installments, and then 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 43,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · nonDerivative · entry 6 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 451,593 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 23,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · nonDerivative · entry 5 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · nonDerivative · entry 4 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · nonDerivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 19, 2020 21:10 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 313 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010863 · doc4.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 19:00 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 17,070 | $1.29 | $21,960.56 |
DisclosureSEC source: 0001567619-20-000435 · doc1.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 356,988 F1 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.25 to $1.30 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 19:00 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 33,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-000435 · doc1.xml · derivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,300 Underlying: Class B Common Stock · 33,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 33.3% of the RSUs vested on December 31, 2018, 33.3% of the RSUs will vest on December 31, 2019 and the remaining 33.3% of the RSUs will vest on December 31, 2020. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be automatically sold on behalf of the Reporting Person to cover any tax withholding obligations. F4 · derivative.expiration_date: 33.3% of the RSUs vested on December 31, 2018, 33.3% of the RSUs will vest on December 31, 2019 and the remaining 33.3% of the RSUs will vest on December 31, 2020. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be automatically sold on behalf of the Reporting Person to cover any tax withholding obligations. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 19:00 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 33,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-000435 · doc1.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 51,482 | $1.34 | $69,130.03 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · nonDerivative · entry 8 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,758 F1 · kind: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $1.275 to $1.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantPerformance Stock Unit (PSU) · Derivative | 344,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · derivative · entry 16 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,828 Underlying: Class B Common Stock · 344,828 shares Expires 2021-08-16 F11 · derivative.exercise_price: (1) Each PSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. The PSU vests on August 17, 2020, subject to the continuing service of the Reporting Person on such date. F11 · derivative.exercise_date: (1) Each PSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. The PSU vests on August 17, 2020, subject to the continuing service of the Reporting Person on such date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 43,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · derivative · entry 15 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 646,553 Underlying: Class B Common Stock · 43,103 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F10 · derivative.exercise_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F10 · derivative.expiration_date: 1/16th of the RSUs vested on November 16, 2019, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 23,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · derivative · entry 14 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,813 Underlying: Class B Common Stock · 23,062 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F9 · derivative.exercise_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F9 · derivative.expiration_date: 1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · derivative · entry 13 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F8 · derivative.exercise_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F8 · derivative.expiration_date: 1/16th of the RSUs vested on August 16, 2018, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · derivative · entry 12 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F7 · derivative.exercise_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F7 · derivative.expiration_date: 1/16th of the RSUs vested on February 16, 2018, and the remainder will vest 1/16th quarterly thereafter in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · derivative · entry 11 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,625 Underlying: Class B Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 1/4th of the RSUs vested on March 7, 2018, the remainder will vest 1/20th quarterly in 12 equal installments, and the remainder will vest 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F6 · derivative.expiration_date: 1/4th of the RSUs vested on March 7, 2018, the remainder will vest 1/20th quarterly in 12 equal installments, and the remainder will vest 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · derivative · entry 10 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313 Underlying: Class B Common Stock · 312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: 1/4th of the RSUs vested on February 24, 2017, the remainder will vest 1/20th quarterly in 12 equal installments, and the remainder will vest 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F5 · derivative.expiration_date: 1/4th of the RSUs vested on February 24, 2017, the remainder will vest 1/20th quarterly in 12 equal installments, and the remainder will vest 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units (RSU) · Derivative | 3,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · derivative · entry 9 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 3,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 1/4th of the RSUs vested on November 16, 2016, the remainder will vest 1/20th quarterly in 12 equal installments, and the remainder will vest 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. F4 · derivative.expiration_date: 1/4th of the RSUs vested on November 16, 2016, the remainder will vest 1/20th quarterly in 12 equal installments, and the remainder will vest 1/12th monthly in equal installments, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 43,103 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · nonDerivative · entry 7 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 392,240 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 23,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · nonDerivative · entry 6 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · nonDerivative · entry 5 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · nonDerivative · entry 4 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · nonDerivative · entry 3 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 312 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2019 Filed Nov 19, 2019 20:11 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 3,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-021907 · doc1.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | SaleClass B Common Stock | 28,171 | $1.41 | $39,605.61 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · nonDerivative · entry 7 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,075 F1 · shares: Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.37 to $1.435 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantRestricted Stock Units (Class B Common Stock) · Derivative | 689,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · derivative · entry 14 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689,656 Underlying: Common Stock · 689,656 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F10 · derivative.exercise_date: The RSUs will vest in equal quarterly installments over four years, beginning on November 16,2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F10 · derivative.expiration_date: The RSUs will vest in equal quarterly installments over four years, beginning on November 16,2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 23,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · derivative · entry 13 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,875 Underlying: Class B Common Stock · 23,063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F9 · derivative.exercise_date: The RSUs vest in equal quarterly installments over four years, beginning on May 16, 2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. F9 · derivative.expiration_date: The RSUs vest in equal quarterly installments over four years, beginning on May 16, 2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · derivative · entry 12 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,500 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F8 · derivative.exercise_date: The RSUs vest over 4 years in 16 equal quarterly installments beginning on August 16, 2018 until fully vested. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting. F8 · derivative.expiration_date: The RSUs vest over 4 years in 16 equal quarterly installments beginning on August 16, 2018 until fully vested. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · derivative · entry 11 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Class B Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F7 · derivative.exercise_date: The RSUs vested and continue to vest in equal quarterly installments over four years, beginning on February 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting. F7 · derivative.expiration_date: The RSUs vested and continue to vest in equal quarterly installments over four years, beginning on February 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · derivative · entry 10 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Class B Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F6 · derivative.exercise_date: The RSUs vest over 5 years as follows: 25% of the RSUs vested on March 7, 2018. Thereafter, the shares vest in 12 quarterly installments each consisting of 5% of the shares subject to the RSU, and 1/12 of the remainder vests monthly thereafter until fully vested. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting. F6 · derivative.expiration_date: The RSUs vest over 5 years as follows: 25% of the RSUs vested on March 7, 2018. Thereafter, the shares vest in 12 quarterly installments each consisting of 5% of the shares subject to the RSU, and 1/12 of the remainder vests monthly thereafter until fully vested. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 313 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · derivative · entry 9 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625 Underlying: Class B Common Stock · 313 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F5 · derivative.exercise_date: The RSUs vest over 5 years as follows: 25% of the RSUs vested on February 24, 2017. Thereafter, the shares vest in 12 quarterly installments each consisting of 5% of the shares subject to the RSU, and 1/12 of the remainder vests monthly thereafter until fully vested. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting. F5 · derivative.expiration_date: The RSUs vest over 5 years as follows: 25% of the RSUs vested on February 24, 2017. Thereafter, the shares vest in 12 quarterly installments each consisting of 5% of the shares subject to the RSU, and 1/12 of the remainder vests monthly thereafter until fully vested. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionRestricted Stock Units · Derivative | 3,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · derivative · entry 8 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,563 Underlying: Class B Common Stock · 3,562 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration. F4 · derivative.exercise_date: The RSUs vest over 5 years as follows: 25% of the restricted stock units ("RSUs") vested on November 16, 2016. Thereafter, the shares vest in 12 quarterly installments each consisting of 5% of the shares subject to the RSU, and 1/12 of the remainder vests monthly thereafter until fully vested. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting. F4 · derivative.expiration_date: The RSUs vest over 5 years as follows: 25% of the restricted stock units ("RSUs") vested on November 16, 2016. Thereafter, the shares vest in 12 quarterly installments each consisting of 5% of the shares subject to the RSU, and 1/12 of the remainder vests monthly thereafter until fully vested. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 23,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · nonDerivative · entry 6 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · nonDerivative · entry 5 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · nonDerivative · entry 4 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · nonDerivative · entry 3 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 313 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · nonDerivative · entry 2 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 19:15 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | Exercise / conversionClass B Common Stock | 3,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-017371 · doc1.xml · nonDerivative · entry 1 O'Meara Maeve · CIK 0001742487 · EVP,Product&CustomerExperience 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.